Israel's EndyMed a top stock on FDA wrinkle treatment approval

February 5, 2015 12:13 PM

3 0

CAESAREA, Israel (Reuters) - One of Israel's best performing stocks in the last year isn't a cybersecurity start-up or a high-tech chipmaker but a firm whose products promise to reduce wrinkles and treat acne.

Shares in EndyMed, which makes devices that use radio waves to rejuvenate skin, have surged 90 percent in the past year, with demand soaring following approval by the U.S. Food and Drug Administration (FDA) for its latest product.

Read more

To category page